4Lipshultz SE, Lipsitz SR, Sallan SE, et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol, 2005, 23:2629-2636.
6Tassan-Mangina S, Codorean D, Metivier M, et al. Tissue Doppler imaging and conventionalechocardiography after anthracycline treatment in adults : early and late alterations of left ventricular function during a prospective study. Eur J Echocardiogr,2006,7 : 141-146.
8[1]Cosme O, Grodman RS. Estimation of left ventricular systolic function by nonvolumetric echocardiographic analysis in subjects with poor left ventricular visualization: a pilot study[J]. Clin Cardiol, 1997, 20(3):247-251.
9[2]Toumanidis ST, Sideris DA, Papamichael CM, et al. The role of mitral annulus motion in left ventricular function[J]. Acta Cardiol, 1992,47(4):331-348.
10[3]Onose Y,Oki T,Mishiro Y, et al. Influence of aging on systolic left ventricular wall motion velocities along the long and short axes in clinically normal patiens determined by pulse tissue Doppler imaging[J]. J Am Soc Echocardiogr, 1999, 12(11):921-926.
4Minotti G,Menna P,Salvatorelli E,et al.Anthracyclines:molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.Pharmacol Rev,2004,56:185-229.
5Jensen BV,Skovsgaard T,Nielsen SL.Functional monitoring of anthracycline cardiotoxicity:a prospective,blinded,long-term observational studu of outcome in 120 patients.Ann Oncol,2002,13:699.
6Kilickap S,Barista I,Akgul E,et al.Ctnt can be a usefulmarker for early detection ofanthracycline cardiotoxicity.Annals of Oncology,2005,16:798-804.
7Maisel S,Koon J,Krishnaswamy P,et al.Utility of BNP as a rapid,point of care test for screening patients under-going echocardiography to determine left ventricular dys-function.Am Heart J,2001,14:367.
8Ho Sup Lee,Chang Bae Son,Seong Hoon Shin,et al.Clinical Correlation between Brain Natriutetic Peptide and Anthracyclin-induced Cardiac Toxicity.Cancer Res Treat,2008,40:121-126.
9Feola M,Garrone O,Occelli M,et al.Cardiotoxicity after anthracycline chemotherapy in breast carcinoma:Effects on left ventricular ejection fraction,troponin I and brain natriuretic peptide.Int J Cardiol,2011,148:194-198.
